An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Knowledge boost: Strengthening the erector spinae (muscles along the spine) and transversus abdominis (the deepest abs) can ...

The 36 teams have discovered their fate for the UEFA Europa League league phase.

Last week New Jersey state court jurors awarded $56 million to the two founders of automotive ecommerce business CARiD.com, $2 million more than the highest damages number put forward by their counsel ...